MicroRNA-124 functions as a tumor suppressor and indicates prognosis in human osteosarcoma

March 2015
Experimental & Therapeutic Medicine;2015, Vol. 9 Issue 3, p679
Academic Journal
MicroRNA-124 (miR-124) has been demonstrated to be downregulated in numerous human malignancies and correlated with tumor progression. However, its expression and clinical significance in osteosarcoma remains unclear. Thus, the aim of the present study was to explore the effects of miR-124 in osteosarcoma tumorigenesis and development. Using reverse transcription-quantitative polymerase chain reaction, miR-124 expression was detected in primary osteosarcoma tissues and osteosarcoma cell lines. The correlation of miR-124 expression with clinicopathological factors and prognosis was statistically analyzed. MTT, flow cytometric, and Transwell invasion and migration assays were used to test the proliferation, apoptosis, invasion and migration of osteosarcoma cells transfected with miR-124 mimic. It was found that the expression levels of miR-124 in osteosarcoma tissues were significantly lower than those in corresponding noncancerous bone tissues (P<0.001). In addition, miR-124 downregulation more frequently occurred in osteosarcoma specimens with advanced clinical stage (P<0.001), positive distant metastasis (P=0.005) and poor response to neoadjuvant chemotherapy (P=0.013). Univariate and multivariate analysis identified low miR-124 expression as an unfavorable prognostic factor for overall survival. Furthermore, transfection of miR-124 mimic into MG63 cells was able to reduce cell proliferation, invasion and migration, and promote cell apoptosis. These findings indicate that miR-124 may act not only as a novel diagnostic and prognostic marker, but also as a potential target for the molecular therapy of osteosarcoma.


Related Articles

  • Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma. Hong-hua Peng; Yang-de Zhang; Lian-sheng Gong; Wei-dong Liu; Yang Zhang // OncoTargets & Therapy;2013, Vol. 6, p1625 

    Background: MicroRNAs (miRNAs) display aberrant expression patterns and functional abnormalities in many types of cancer. However, their roles in primary gallbladder carcinoma (PGC) have not been well documented. miR-335 has been demonstrated to be involved in tumorigenesis of several cancers in...

  • Protein inhibitor of activated STAT xα depresses cyclin D and cyclin D kinase, and contributes to the inhibition of osteosarcoma cell progression. JUNJIE WANG; JIANGDONG NI; SHUAI YI; DEYE SONG; MULIANG DING // Molecular Medicine Reports;2016, Vol. 13 Issue 2, p1645 

    activated STAT (PIAs)xa is crucial in protein sumoylation and is associated with cancer cell progression. However, the mechanism underlying the inhibitory effect on cancer cells, which may assist in developing novel treatment strategies in cancer remains to be elucidated. In present study, the...

  • Knockdown of PREX2a inhibits the malignant phenotype of osteosarcoma cells. ZIXUN DAI; JIE XIE; PENGFEI LEI; YIHE HU // Molecular Medicine Reports;2016, Vol. 13 Issue 2, p1930 

    Phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2a (PREX2a), which is a regulator of the small guanosine triphosphatase Rac, has recently been reported to have an oncogenic role via the suppression of phosphatase and tensin homolog deleted on chromosome ten (PTEN)...

  • Combined MicroRNA-340 and ROCK1 mRNA Profiling Predicts Tumor Progression and Prognosis in Pediatric Osteosarcoma. Haiqing Cai; Lijun Lin; Haikang Cai; Mingjie Tang; Zhigang Wang // International Journal of Molecular Sciences;Jan2014, Vol. 15 Issue 1, p560 

    To investigate the association of combined microRNA-340 (miR-340) and ROCK1 mRNA profiling with clinicopathologic features and prognosis in pediatric patients with osteosarcoma. Quantitative real-time reverse transcriptase-polymerase chain reaction analysis was performed to detect expression...

  • Pulmonary metastasectomy for osteogenic and soft tissue sarcoma: who really benefits from surgical treatment? Mizuno, Tetsuya; Taniguchi, Tetsuo; Ishikawa, Yoshinori; Kawaguchi, Koji; Fukui, Takayuki; Ishiguro, Futoshi; Nakamura, Shota; Yokoi, Kohei // European Journal of Cardio-Thoracic Surgery;Apr2013, Vol. 43 Issue 4, p795 

    OBJECTIVES Surgical resection is widely accepted as a beneficial treatment of pulmonary metastases originating from osteogenic and soft tissue sarcomas despite adequate validation. The factors associated with the selection of patients who receive pulmonary metastasectomy (PM) are controversial...

  • Low expression of LOC285194 is associated with poor prognosis in colorectal cancer. Peng Qi; Mi-die Xu; Shu-juan Ni; Dan Huang; Ping Wei; Cong Tan; Xiao-yan Zhou; Xiang Du // Journal of Translational Medicine;2013, Vol. 11 Issue 1, p1 

    Background: The long non-coding RNAs (lncRNAs) study has gradually become one of the hot topics in the field of RNA biology. One lncRNA which has attracted attention is LOC285194, a lncRNA demonstrated the potential tumor-suppressor role in osteosarcoma. The aim of this study was to examine the...

  • Interferon-α/β Receptor as a Prognostic. Marker in Osteosarcoma. Kubo, Tadahiko; Shimose, Shoji; Matsuo, Toshihiro; Fujimori, Jun; Arihiro, Koji; Ochi, Mitsuo // Journal of Bone & Joint Surgery, American Volume;3/16/2011, Vol. 93-A Issue 6, p519 

    Background: A large-scale randomized trial of adjuvant interferon-α therapy for patients with osteosarcoma has been initiated as a joint protocol by the European and American Osteosarcoma Study Group. Because the expression of functional interferon-α/β receptor is necessary for...

  • Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma. Ming-Qi Fan; Chi-Bing Huang; Yan Gu; Ya Xiao; Jin-Xin Sheng; Lin Zhong // Journal of Experimental & Clinical Cancer Research (17569966);2013, Vol. 32 Issue 1, p1 

    Background: Growing evidences indicate microRNAs play important roles in cancer development, progression, metastasis and may constitute robust biomarkers for cancer prognosis. The aim of this study was to identify the clinical and functional association of microRNA-20a (miR-20a) in...

  • Targeting Inflammatory Kinase as an Adjuvant Treatment for Osteosarcomas. Noh, Kyucheol; Kim, Kyung-Ok; Patel, Neel R.; Staples, J. Robert; Minematsu, Hiroshi; Nair, Kumar; Lee, Francis Young-In // Journal of Bone & Joint Surgery, American Volume;4/20/2011, Vol. 93-A Issue 8, p723 

    Background: A subset of patients with aggressive osteosarcomas responds poorly to conventional cytotoxic chemotherapy. Recent evidence from studies involving the liver, skin, stomach, and colon suggests that carcinogenesis is associated with inflammation. Mitogen-activated protein kinase...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics